nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—RALBP1—Sorafenib—liver cancer	0.288	0.391	CbGbCtD
Carbamazepine—RALBP1—Doxorubicin—liver cancer	0.175	0.237	CbGbCtD
Carbamazepine—UGT2B7—Epirubicin—liver cancer	0.0657	0.089	CbGbCtD
Carbamazepine—ABCC2—Sorafenib—liver cancer	0.0302	0.041	CbGbCtD
Carbamazepine—ABCC2—bile canaliculus—liver cancer	0.0253	0.546	CbGeAlD
Carbamazepine—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0202	0.0274	CbGbCtD
Carbamazepine—CYP3A7—Sorafenib—liver cancer	0.0202	0.0274	CbGbCtD
Carbamazepine—CYP2B6—Sorafenib—liver cancer	0.0192	0.0261	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—liver cancer	0.0184	0.0249	CbGbCtD
Carbamazepine—CYP3A5—Sorafenib—liver cancer	0.0152	0.0205	CbGbCtD
Carbamazepine—CYP2C8—Sorafenib—liver cancer	0.0146	0.0197	CbGbCtD
Carbamazepine—CYP2C19—Sorafenib—liver cancer	0.0122	0.0166	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—liver cancer	0.0117	0.0158	CbGbCtD
Carbamazepine—CYP1A2—Sorafenib—liver cancer	0.0113	0.0153	CbGbCtD
Carbamazepine—CYP2C9—Sorafenib—liver cancer	0.0102	0.0138	CbGbCtD
Carbamazepine—ABCB1—Sorafenib—liver cancer	0.00986	0.0134	CbGbCtD
Carbamazepine—ABCC2—bile duct—liver cancer	0.00789	0.171	CbGeAlD
Carbamazepine—ABCC2—bile—liver cancer	0.00606	0.131	CbGeAlD
Carbamazepine—ABCB1—Doxorubicin—liver cancer	0.00598	0.00811	CbGbCtD
Carbamazepine—CYP3A4—Sorafenib—liver cancer	0.00591	0.00801	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—liver cancer	0.00358	0.00486	CbGbCtD
Carbamazepine—CYP3A7—liver—liver cancer	0.000949	0.0205	CbGeAlD
Carbamazepine—UGT2B7—liver—liver cancer	0.00092	0.0199	CbGeAlD
Carbamazepine—RALBP1—liver—liver cancer	0.00092	0.0199	CbGeAlD
Carbamazepine—CYP3A7-CYP3A51P—liver—liver cancer	0.000807	0.0174	CbGeAlD
Carbamazepine—ABCC2—liver—liver cancer	0.000493	0.0107	CbGeAlD
Carbamazepine—CYP2C19—liver—liver cancer	0.000424	0.00917	CbGeAlD
Carbamazepine—ABCB1—embryo—liver cancer	0.000384	0.0083	CbGeAlD
Carbamazepine—CYP2C8—liver—liver cancer	0.00037	0.008	CbGeAlD
Carbamazepine—CYP1A2—liver—liver cancer	0.000346	0.00749	CbGeAlD
Carbamazepine—CYP3A5—liver—liver cancer	0.000334	0.00722	CbGeAlD
Carbamazepine—CYP2B6—liver—liver cancer	0.000332	0.00718	CbGeAlD
Carbamazepine—CYP2C9—liver—liver cancer	0.000329	0.00711	CbGeAlD
Carbamazepine—CYP3A4—liver—liver cancer	0.000251	0.00542	CbGeAlD
Carbamazepine—Purpura—Epirubicin—liver cancer	0.00021	0.00173	CcSEcCtD
Carbamazepine—Vascular purpura—Doxorubicin—liver cancer	0.00021	0.00172	CcSEcCtD
Carbamazepine—Hepatic failure—Doxorubicin—liver cancer	0.000209	0.00172	CcSEcCtD
Carbamazepine—Cardiac failure—Epirubicin—liver cancer	0.000208	0.00171	CcSEcCtD
Carbamazepine—Lethargy—Epirubicin—liver cancer	0.000207	0.0017	CcSEcCtD
Carbamazepine—Cardiac failure congestive—Doxorubicin—liver cancer	0.000207	0.0017	CcSEcCtD
Carbamazepine—Hyponatraemia—Epirubicin—liver cancer	0.000204	0.00167	CcSEcCtD
Carbamazepine—Osteoarthritis—Epirubicin—liver cancer	0.000203	0.00167	CcSEcCtD
Carbamazepine—Diplopia—Epirubicin—liver cancer	0.000203	0.00167	CcSEcCtD
Carbamazepine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000199	0.00163	CcSEcCtD
Carbamazepine—Hypersensitivity—Sorafenib—liver cancer	0.000199	0.00163	CcSEcCtD
Carbamazepine—Renal impairment—Doxorubicin—liver cancer	0.000197	0.00162	CcSEcCtD
Carbamazepine—Dermatitis bullous—Doxorubicin—liver cancer	0.000196	0.00161	CcSEcCtD
Carbamazepine—Purpura—Doxorubicin—liver cancer	0.000195	0.0016	CcSEcCtD
Carbamazepine—Asthenia—Sorafenib—liver cancer	0.000194	0.00159	CcSEcCtD
Carbamazepine—Cardiac arrest—Epirubicin—liver cancer	0.000193	0.00158	CcSEcCtD
Carbamazepine—Cardiac failure—Doxorubicin—liver cancer	0.000192	0.00158	CcSEcCtD
Carbamazepine—Lethargy—Doxorubicin—liver cancer	0.000192	0.00157	CcSEcCtD
Carbamazepine—Pruritus—Sorafenib—liver cancer	0.000191	0.00157	CcSEcCtD
Carbamazepine—Ataxia—Epirubicin—liver cancer	0.000191	0.00157	CcSEcCtD
Carbamazepine—Hyponatraemia—Doxorubicin—liver cancer	0.000188	0.00155	CcSEcCtD
Carbamazepine—Osteoarthritis—Doxorubicin—liver cancer	0.000188	0.00154	CcSEcCtD
Carbamazepine—Diplopia—Doxorubicin—liver cancer	0.000188	0.00154	CcSEcCtD
Carbamazepine—Liver function test abnormal—Epirubicin—liver cancer	0.000187	0.00154	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Epirubicin—liver cancer	0.000185	0.00152	CcSEcCtD
Carbamazepine—Hypokalaemia—Epirubicin—liver cancer	0.000185	0.00152	CcSEcCtD
Carbamazepine—Diarrhoea—Sorafenib—liver cancer	0.000185	0.00152	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000183	0.0015	CcSEcCtD
Carbamazepine—Muscular weakness—Epirubicin—liver cancer	0.000179	0.00147	CcSEcCtD
Carbamazepine—Cardiac arrest—Doxorubicin—liver cancer	0.000178	0.00147	CcSEcCtD
Carbamazepine—Dizziness—Sorafenib—liver cancer	0.000178	0.00147	CcSEcCtD
Carbamazepine—ABCB1—liver—liver cancer	0.000177	0.00384	CbGeAlD
Carbamazepine—Ataxia—Doxorubicin—liver cancer	0.000176	0.00145	CcSEcCtD
Carbamazepine—Dysphagia—Epirubicin—liver cancer	0.000175	0.00144	CcSEcCtD
Carbamazepine—Eosinophilia—Epirubicin—liver cancer	0.000174	0.00143	CcSEcCtD
Carbamazepine—Liver function test abnormal—Doxorubicin—liver cancer	0.000173	0.00142	CcSEcCtD
Carbamazepine—Pancreatitis—Epirubicin—liver cancer	0.000172	0.00141	CcSEcCtD
Carbamazepine—Vomiting—Sorafenib—liver cancer	0.000172	0.00141	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000171	0.00141	CcSEcCtD
Carbamazepine—Hypokalaemia—Doxorubicin—liver cancer	0.000171	0.0014	CcSEcCtD
Carbamazepine—Rash—Sorafenib—liver cancer	0.00017	0.0014	CcSEcCtD
Carbamazepine—Dermatitis—Sorafenib—liver cancer	0.00017	0.0014	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000169	0.00139	CcSEcCtD
Carbamazepine—Headache—Sorafenib—liver cancer	0.000169	0.00139	CcSEcCtD
Carbamazepine—Bronchitis—Epirubicin—liver cancer	0.000169	0.00139	CcSEcCtD
Carbamazepine—Pancytopenia—Epirubicin—liver cancer	0.000167	0.00137	CcSEcCtD
Carbamazepine—Muscular weakness—Doxorubicin—liver cancer	0.000166	0.00136	CcSEcCtD
Carbamazepine—Dysphagia—Doxorubicin—liver cancer	0.000162	0.00133	CcSEcCtD
Carbamazepine—Pollakiuria—Epirubicin—liver cancer	0.000162	0.00133	CcSEcCtD
Carbamazepine—Eosinophilia—Doxorubicin—liver cancer	0.000161	0.00132	CcSEcCtD
Carbamazepine—Nausea—Sorafenib—liver cancer	0.00016	0.00132	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Epirubicin—liver cancer	0.00016	0.00131	CcSEcCtD
Carbamazepine—Weight increased—Epirubicin—liver cancer	0.00016	0.00131	CcSEcCtD
Carbamazepine—Pancreatitis—Doxorubicin—liver cancer	0.000159	0.00131	CcSEcCtD
Carbamazepine—Hyperglycaemia—Epirubicin—liver cancer	0.000158	0.0013	CcSEcCtD
Carbamazepine—Pneumonia—Epirubicin—liver cancer	0.000157	0.00129	CcSEcCtD
Carbamazepine—Infestation NOS—Epirubicin—liver cancer	0.000156	0.00128	CcSEcCtD
Carbamazepine—Drowsiness—Epirubicin—liver cancer	0.000156	0.00128	CcSEcCtD
Carbamazepine—Infestation—Epirubicin—liver cancer	0.000156	0.00128	CcSEcCtD
Carbamazepine—Bronchitis—Doxorubicin—liver cancer	0.000156	0.00128	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000155	0.00127	CcSEcCtD
Carbamazepine—Pancytopenia—Doxorubicin—liver cancer	0.000154	0.00127	CcSEcCtD
Carbamazepine—Renal failure—Epirubicin—liver cancer	0.000154	0.00126	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Epirubicin—liver cancer	0.000153	0.00126	CcSEcCtD
Carbamazepine—Stomatitis—Epirubicin—liver cancer	0.000152	0.00125	CcSEcCtD
Carbamazepine—Jaundice—Epirubicin—liver cancer	0.000152	0.00125	CcSEcCtD
Carbamazepine—Urinary tract infection—Epirubicin—liver cancer	0.000152	0.00125	CcSEcCtD
Carbamazepine—Conjunctivitis—Epirubicin—liver cancer	0.000152	0.00125	CcSEcCtD
Carbamazepine—Pollakiuria—Doxorubicin—liver cancer	0.00015	0.00123	CcSEcCtD
Carbamazepine—Haematuria—Epirubicin—liver cancer	0.000149	0.00122	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000148	0.00122	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Epirubicin—liver cancer	0.000148	0.00121	CcSEcCtD
Carbamazepine—Weight increased—Doxorubicin—liver cancer	0.000148	0.00121	CcSEcCtD
Carbamazepine—Sinusitis—Epirubicin—liver cancer	0.000147	0.0012	CcSEcCtD
Carbamazepine—Hyperglycaemia—Doxorubicin—liver cancer	0.000146	0.0012	CcSEcCtD
Carbamazepine—Agranulocytosis—Epirubicin—liver cancer	0.000146	0.0012	CcSEcCtD
Carbamazepine—Pneumonia—Doxorubicin—liver cancer	0.000145	0.0012	CcSEcCtD
Carbamazepine—Drowsiness—Doxorubicin—liver cancer	0.000145	0.00119	CcSEcCtD
Carbamazepine—Infestation—Doxorubicin—liver cancer	0.000145	0.00119	CcSEcCtD
Carbamazepine—Infestation NOS—Doxorubicin—liver cancer	0.000145	0.00119	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000143	0.00118	CcSEcCtD
Carbamazepine—Bradycardia—Epirubicin—liver cancer	0.000143	0.00117	CcSEcCtD
Carbamazepine—Renal failure—Doxorubicin—liver cancer	0.000142	0.00117	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000142	0.00116	CcSEcCtD
Carbamazepine—Stomatitis—Doxorubicin—liver cancer	0.000141	0.00116	CcSEcCtD
Carbamazepine—Jaundice—Doxorubicin—liver cancer	0.000141	0.00116	CcSEcCtD
Carbamazepine—Rhinitis—Epirubicin—liver cancer	0.000141	0.00116	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—liver cancer	0.000141	0.00115	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—liver cancer	0.000141	0.00115	CcSEcCtD
Carbamazepine—Hepatitis—Epirubicin—liver cancer	0.00014	0.00115	CcSEcCtD
Carbamazepine—Pharyngitis—Epirubicin—liver cancer	0.000139	0.00114	CcSEcCtD
Carbamazepine—Urinary tract disorder—Epirubicin—liver cancer	0.000139	0.00114	CcSEcCtD
Carbamazepine—Oedema peripheral—Epirubicin—liver cancer	0.000138	0.00114	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—liver cancer	0.000138	0.00113	CcSEcCtD
Carbamazepine—Connective tissue disorder—Epirubicin—liver cancer	0.000138	0.00113	CcSEcCtD
Carbamazepine—Urethral disorder—Epirubicin—liver cancer	0.000138	0.00113	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000137	0.00112	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—liver cancer	0.000136	0.00111	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—liver cancer	0.000135	0.00111	CcSEcCtD
Carbamazepine—Erythema multiforme—Epirubicin—liver cancer	0.000133	0.00109	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—liver cancer	0.000132	0.00109	CcSEcCtD
Carbamazepine—Eye disorder—Epirubicin—liver cancer	0.000131	0.00108	CcSEcCtD
Carbamazepine—Tinnitus—Epirubicin—liver cancer	0.000131	0.00107	CcSEcCtD
Carbamazepine—Flushing—Epirubicin—liver cancer	0.00013	0.00107	CcSEcCtD
Carbamazepine—Cardiac disorder—Epirubicin—liver cancer	0.00013	0.00107	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—liver cancer	0.00013	0.00107	CcSEcCtD
Carbamazepine—Hepatitis—Doxorubicin—liver cancer	0.00013	0.00107	CcSEcCtD
Carbamazepine—Pharyngitis—Doxorubicin—liver cancer	0.000129	0.00106	CcSEcCtD
Carbamazepine—Urinary tract disorder—Doxorubicin—liver cancer	0.000128	0.00105	CcSEcCtD
Carbamazepine—Oedema peripheral—Doxorubicin—liver cancer	0.000128	0.00105	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—liver cancer	0.000128	0.00105	CcSEcCtD
Carbamazepine—Angiopathy—Epirubicin—liver cancer	0.000127	0.00105	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—liver cancer	0.000127	0.00105	CcSEcCtD
Carbamazepine—Immune system disorder—Epirubicin—liver cancer	0.000127	0.00104	CcSEcCtD
Carbamazepine—Mediastinal disorder—Epirubicin—liver cancer	0.000126	0.00104	CcSEcCtD
Carbamazepine—Chills—Epirubicin—liver cancer	0.000126	0.00103	CcSEcCtD
Carbamazepine—Arrhythmia—Epirubicin—liver cancer	0.000125	0.00103	CcSEcCtD
Carbamazepine—Alopecia—Epirubicin—liver cancer	0.000124	0.00102	CcSEcCtD
Carbamazepine—Mental disorder—Epirubicin—liver cancer	0.000123	0.00101	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—liver cancer	0.000123	0.00101	CcSEcCtD
Carbamazepine—Erythema—Epirubicin—liver cancer	0.000122	0.001	CcSEcCtD
Carbamazepine—Malnutrition—Epirubicin—liver cancer	0.000122	0.001	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—liver cancer	0.000121	0.000997	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—liver cancer	0.000121	0.000995	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—liver cancer	0.000121	0.00099	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—liver cancer	0.000121	0.00099	CcSEcCtD
Carbamazepine—Tension—Epirubicin—liver cancer	0.00012	0.000985	CcSEcCtD
Carbamazepine—Dysgeusia—Epirubicin—liver cancer	0.00012	0.000983	CcSEcCtD
Carbamazepine—Nervousness—Epirubicin—liver cancer	0.000119	0.000975	CcSEcCtD
Carbamazepine—Back pain—Epirubicin—liver cancer	0.000118	0.000971	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—liver cancer	0.000118	0.000968	CcSEcCtD
Carbamazepine—Muscle spasms—Epirubicin—liver cancer	0.000117	0.000965	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—liver cancer	0.000117	0.000963	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—liver cancer	0.000117	0.000961	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—liver cancer	0.000117	0.000957	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—liver cancer	0.000116	0.000953	CcSEcCtD
Carbamazepine—Vision blurred—Epirubicin—liver cancer	0.000115	0.000946	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—liver cancer	0.000115	0.000943	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—liver cancer	0.000114	0.000934	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—liver cancer	0.000113	0.000929	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—liver cancer	0.000113	0.000929	CcSEcCtD
Carbamazepine—Anaemia—Epirubicin—liver cancer	0.000113	0.000928	CcSEcCtD
Carbamazepine—Agitation—Epirubicin—liver cancer	0.000112	0.000922	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—liver cancer	0.000111	0.000911	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—liver cancer	0.000111	0.000909	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—liver cancer	0.00011	0.000902	CcSEcCtD
Carbamazepine—Vertigo—Epirubicin—liver cancer	0.00011	0.000902	CcSEcCtD
Carbamazepine—Syncope—Epirubicin—liver cancer	0.00011	0.0009	CcSEcCtD
Carbamazepine—Leukopenia—Epirubicin—liver cancer	0.000109	0.000898	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—liver cancer	0.000109	0.000898	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—liver cancer	0.000109	0.000893	CcSEcCtD
Carbamazepine—Loss of consciousness—Epirubicin—liver cancer	0.000107	0.000882	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—liver cancer	0.000107	0.000875	CcSEcCtD
Carbamazepine—Convulsion—Epirubicin—liver cancer	0.000106	0.000869	CcSEcCtD
Carbamazepine—Hypertension—Epirubicin—liver cancer	0.000105	0.000866	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—liver cancer	0.000104	0.000858	CcSEcCtD
Carbamazepine—Myalgia—Epirubicin—liver cancer	0.000104	0.000854	CcSEcCtD
Carbamazepine—Chest pain—Epirubicin—liver cancer	0.000104	0.000854	CcSEcCtD
Carbamazepine—Arthralgia—Epirubicin—liver cancer	0.000104	0.000854	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—liver cancer	0.000104	0.000853	CcSEcCtD
Carbamazepine—Anxiety—Epirubicin—liver cancer	0.000104	0.000851	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000103	0.000848	CcSEcCtD
Carbamazepine—Dry mouth—Epirubicin—liver cancer	0.000102	0.000836	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—liver cancer	0.000102	0.000834	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—liver cancer	0.000101	0.000833	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—liver cancer	0.000101	0.000831	CcSEcCtD
Carbamazepine—Confusional state—Epirubicin—liver cancer	0.000101	0.000826	CcSEcCtD
Carbamazepine—Anaphylactic shock—Epirubicin—liver cancer	9.97e-05	0.000819	CcSEcCtD
Carbamazepine—Oedema—Epirubicin—liver cancer	9.97e-05	0.000819	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—liver cancer	9.94e-05	0.000816	CcSEcCtD
Carbamazepine—Infection—Epirubicin—liver cancer	9.91e-05	0.000814	CcSEcCtD
Carbamazepine—Shock—Epirubicin—liver cancer	9.81e-05	0.000806	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—liver cancer	9.79e-05	0.000805	CcSEcCtD
Carbamazepine—Nervous system disorder—Epirubicin—liver cancer	9.78e-05	0.000803	CcSEcCtD
Carbamazepine—Thrombocytopenia—Epirubicin—liver cancer	9.76e-05	0.000802	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—liver cancer	9.76e-05	0.000802	CcSEcCtD
Carbamazepine—Tachycardia—Epirubicin—liver cancer	9.73e-05	0.000799	CcSEcCtD
Carbamazepine—Skin disorder—Epirubicin—liver cancer	9.68e-05	0.000796	CcSEcCtD
Carbamazepine—Hyperhidrosis—Epirubicin—liver cancer	9.64e-05	0.000792	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—liver cancer	9.62e-05	0.000791	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—liver cancer	9.62e-05	0.000791	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—liver cancer	9.62e-05	0.000791	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—liver cancer	9.59e-05	0.000788	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	9.56e-05	0.000785	CcSEcCtD
Carbamazepine—Anorexia—Epirubicin—liver cancer	9.5e-05	0.000781	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—liver cancer	9.41e-05	0.000773	CcSEcCtD
Carbamazepine—Hypotension—Epirubicin—liver cancer	9.32e-05	0.000765	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—liver cancer	9.3e-05	0.000764	CcSEcCtD
Carbamazepine—Oedema—Doxorubicin—liver cancer	9.23e-05	0.000758	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—liver cancer	9.23e-05	0.000758	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—liver cancer	9.17e-05	0.000753	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Epirubicin—liver cancer	9.08e-05	0.000746	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—liver cancer	9.08e-05	0.000746	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—liver cancer	9.05e-05	0.000743	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—liver cancer	9.03e-05	0.000742	CcSEcCtD
Carbamazepine—Insomnia—Epirubicin—liver cancer	9.02e-05	0.000741	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—liver cancer	9e-05	0.00074	CcSEcCtD
Carbamazepine—Skin disorder—Doxorubicin—liver cancer	8.96e-05	0.000736	CcSEcCtD
Carbamazepine—Paraesthesia—Epirubicin—liver cancer	8.95e-05	0.000735	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—liver cancer	8.92e-05	0.000733	CcSEcCtD
Carbamazepine—Dyspnoea—Epirubicin—liver cancer	8.89e-05	0.00073	CcSEcCtD
Carbamazepine—Somnolence—Epirubicin—liver cancer	8.86e-05	0.000728	CcSEcCtD
Carbamazepine—Anorexia—Doxorubicin—liver cancer	8.79e-05	0.000722	CcSEcCtD
Carbamazepine—Dyspepsia—Epirubicin—liver cancer	8.78e-05	0.000721	CcSEcCtD
Carbamazepine—Decreased appetite—Epirubicin—liver cancer	8.67e-05	0.000712	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—liver cancer	8.62e-05	0.000708	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Epirubicin—liver cancer	8.61e-05	0.000707	CcSEcCtD
Carbamazepine—Fatigue—Epirubicin—liver cancer	8.6e-05	0.000706	CcSEcCtD
Carbamazepine—Pain—Epirubicin—liver cancer	8.53e-05	0.0007	CcSEcCtD
Carbamazepine—Constipation—Epirubicin—liver cancer	8.53e-05	0.0007	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—liver cancer	8.4e-05	0.00069	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—liver cancer	8.34e-05	0.000685	CcSEcCtD
Carbamazepine—Paraesthesia—Doxorubicin—liver cancer	8.28e-05	0.00068	CcSEcCtD
Carbamazepine—Dyspnoea—Doxorubicin—liver cancer	8.22e-05	0.000676	CcSEcCtD
Carbamazepine—Feeling abnormal—Epirubicin—liver cancer	8.22e-05	0.000675	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—liver cancer	8.2e-05	0.000674	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Epirubicin—liver cancer	8.15e-05	0.00067	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—liver cancer	8.12e-05	0.000667	CcSEcCtD
Carbamazepine—Decreased appetite—Doxorubicin—liver cancer	8.02e-05	0.000659	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—liver cancer	7.96e-05	0.000654	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—liver cancer	7.95e-05	0.000653	CcSEcCtD
Carbamazepine—Urticaria—Epirubicin—liver cancer	7.92e-05	0.000651	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—liver cancer	7.89e-05	0.000648	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—liver cancer	7.89e-05	0.000648	CcSEcCtD
Carbamazepine—Abdominal pain—Epirubicin—liver cancer	7.88e-05	0.000647	CcSEcCtD
Carbamazepine—Body temperature increased—Epirubicin—liver cancer	7.88e-05	0.000647	CcSEcCtD
Carbamazepine—Magnesium salicylate—ALB—liver cancer	7.83e-05	0.345	CrCbGaD
Carbamazepine—Feeling abnormal—Doxorubicin—liver cancer	7.6e-05	0.000624	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—liver cancer	7.54e-05	0.00062	CcSEcCtD
Carbamazepine—Hypersensitivity—Epirubicin—liver cancer	7.35e-05	0.000603	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—liver cancer	7.33e-05	0.000602	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—liver cancer	7.29e-05	0.000599	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—liver cancer	7.29e-05	0.000599	CcSEcCtD
Carbamazepine—Asthenia—Epirubicin—liver cancer	7.15e-05	0.000588	CcSEcCtD
Carbamazepine—Pruritus—Epirubicin—liver cancer	7.05e-05	0.000579	CcSEcCtD
Carbamazepine—Diarrhoea—Epirubicin—liver cancer	6.82e-05	0.00056	CcSEcCtD
Carbamazepine—Hypersensitivity—Doxorubicin—liver cancer	6.8e-05	0.000558	CcSEcCtD
Carbamazepine—Asthenia—Doxorubicin—liver cancer	6.62e-05	0.000544	CcSEcCtD
Carbamazepine—Dizziness—Epirubicin—liver cancer	6.59e-05	0.000542	CcSEcCtD
Carbamazepine—Pruritus—Doxorubicin—liver cancer	6.53e-05	0.000536	CcSEcCtD
Carbamazepine—Vomiting—Epirubicin—liver cancer	6.34e-05	0.000521	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—liver cancer	6.31e-05	0.000519	CcSEcCtD
Carbamazepine—Rash—Epirubicin—liver cancer	6.29e-05	0.000516	CcSEcCtD
Carbamazepine—Dermatitis—Epirubicin—liver cancer	6.28e-05	0.000516	CcSEcCtD
Carbamazepine—Headache—Epirubicin—liver cancer	6.25e-05	0.000513	CcSEcCtD
Carbamazepine—Dizziness—Doxorubicin—liver cancer	6.1e-05	0.000501	CcSEcCtD
Carbamazepine—Nausea—Epirubicin—liver cancer	5.92e-05	0.000486	CcSEcCtD
Carbamazepine—Vomiting—Doxorubicin—liver cancer	5.87e-05	0.000482	CcSEcCtD
Carbamazepine—Rash—Doxorubicin—liver cancer	5.82e-05	0.000478	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—liver cancer	5.81e-05	0.000477	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—liver cancer	5.78e-05	0.000475	CcSEcCtD
Carbamazepine—Nausea—Doxorubicin—liver cancer	5.48e-05	0.00045	CcSEcCtD
Carbamazepine—Oxcarbazepine—ALB—liver cancer	4.62e-05	0.204	CrCbGaD
Carbamazepine—Desipramine—CYP2E1—liver cancer	3.88e-05	0.171	CrCbGaD
Carbamazepine—Imipramine—CYP2E1—liver cancer	3.29e-05	0.145	CrCbGaD
Carbamazepine—Phenytoin—ALB—liver cancer	3.06e-05	0.135	CrCbGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.01e-05	0.000107	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CG—liver cancer	1.01e-05	0.000107	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALDOB—liver cancer	1e-05	0.000107	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1e-05	0.000107	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTA2—liver cancer	1e-05	0.000106	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—liver cancer	9.98e-06	0.000106	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—HMOX1—liver cancer	9.93e-06	0.000106	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PSMD10—liver cancer	9.87e-06	0.000105	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PSMA4—liver cancer	9.87e-06	0.000105	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALDOB—liver cancer	9.8e-06	0.000104	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NR1H4—liver cancer	9.76e-06	0.000104	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PPARG—liver cancer	9.7e-06	0.000103	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.66e-06	0.000103	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTA1—liver cancer	9.65e-06	0.000103	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PSMD10—liver cancer	9.65e-06	0.000103	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PSMA4—liver cancer	9.65e-06	0.000103	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GOT2—liver cancer	9.6e-06	0.000102	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTA3—liver cancer	9.59e-06	0.000102	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CRABP1—liver cancer	9.57e-06	0.000102	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL6—liver cancer	9.55e-06	0.000101	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NAT2—liver cancer	9.54e-06	0.000101	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	9.41e-06	0.0001	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GOT2—liver cancer	9.39e-06	9.97e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HPGDS—liver cancer	9.38e-06	9.96e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CRABP1—liver cancer	9.34e-06	9.93e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	9.34e-06	9.93e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.32e-06	9.9e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GSTM1—liver cancer	9.25e-06	9.83e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.18e-06	9.75e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALDOB—liver cancer	9.15e-06	9.72e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	9.1e-06	9.68e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP2E1—liver cancer	9.03e-06	9.59e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CD—liver cancer	8.84e-06	9.39e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP2E1—liver cancer	8.82e-06	9.38e-05	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—AKT1—liver cancer	8.81e-06	9.36e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTA4—liver cancer	8.77e-06	9.32e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP1A1—liver cancer	8.77e-06	9.32e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CRABP1—liver cancer	8.73e-06	9.28e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ALB—liver cancer	8.72e-06	9.27e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.62e-06	9.16e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	8.57e-06	9.11e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTA2—liver cancer	8.55e-06	9.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.49e-06	9.02e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYCS—liver cancer	8.45e-06	8.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.38e-06	8.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HPGDS—liver cancer	8.37e-06	8.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PSMD10—liver cancer	8.36e-06	8.88e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PSMA4—liver cancer	8.36e-06	8.88e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.32e-06	8.84e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GOT1—liver cancer	8.29e-06	8.81e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GGT1—liver cancer	8.29e-06	8.81e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYCS—liver cancer	8.26e-06	8.77e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTA1—liver cancer	8.25e-06	8.77e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—MTHFR—liver cancer	8.18e-06	8.69e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HPGDS—liver cancer	8.17e-06	8.68e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NAT2—liver cancer	8.16e-06	8.67e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GOT2—liver cancer	8.13e-06	8.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GGT1—liver cancer	8.1e-06	8.61e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GOT1—liver cancer	8.1e-06	8.61e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARA—liver cancer	8.02e-06	8.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.86e-06	8.35e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.84e-06	8.33e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALDOB—liver cancer	7.82e-06	8.31e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CPT1B—liver cancer	7.81e-06	8.3e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GLUL—liver cancer	7.81e-06	8.3e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CB—liver cancer	7.7e-06	8.18e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	7.69e-06	8.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP2E1—liver cancer	7.64e-06	8.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HPGDS—liver cancer	7.63e-06	8.11e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.59e-06	8.06e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.58e-06	8.05e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NR1H4—liver cancer	7.53e-06	8e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.48e-06	7.95e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CRABP1—liver cancer	7.46e-06	7.93e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PSMA4—liver cancer	7.46e-06	7.93e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PSMD10—liver cancer	7.46e-06	7.93e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTP1—liver cancer	7.45e-06	7.91e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTA3—liver cancer	7.4e-06	7.87e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.4e-06	7.86e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—HMOX1—liver cancer	7.34e-06	7.8e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PSMA4—liver cancer	7.28e-06	7.74e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PSMD10—liver cancer	7.28e-06	7.74e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTP1—liver cancer	7.28e-06	7.73e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GOT2—liver cancer	7.26e-06	7.71e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HMOX1—liver cancer	7.18e-06	7.63e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYCS—liver cancer	7.15e-06	7.6e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GOT2—liver cancer	7.08e-06	7.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GGT1—liver cancer	7.02e-06	7.46e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GOT1—liver cancer	7.02e-06	7.46e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	6.94e-06	7.38e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.91e-06	7.34e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CG—liver cancer	6.87e-06	7.3e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTM1—liver cancer	6.84e-06	7.27e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP2E1—liver cancer	6.82e-06	7.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.82e-06	7.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PSMA4—liver cancer	6.8e-06	7.23e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PSMD10—liver cancer	6.8e-06	7.23e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTA4—liver cancer	6.77e-06	7.2e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.72e-06	7.14e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTM1—liver cancer	6.69e-06	7.11e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP2E1—liver cancer	6.66e-06	7.08e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARG—liver cancer	6.63e-06	7.05e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GOT2—liver cancer	6.62e-06	7.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.61e-06	7.02e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTA2—liver cancer	6.6e-06	7.01e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HPGDS—liver cancer	6.52e-06	6.93e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP1A1—liver cancer	6.49e-06	6.89e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.48e-06	6.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYCS—liver cancer	6.38e-06	6.78e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTA1—liver cancer	6.37e-06	6.77e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP1A1—liver cancer	6.34e-06	6.74e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTP1—liver cancer	6.3e-06	6.7e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NAT2—liver cancer	6.29e-06	6.69e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	6.28e-06	6.67e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GOT1—liver cancer	6.26e-06	6.66e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GGT1—liver cancer	6.26e-06	6.66e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYCS—liver cancer	6.23e-06	6.62e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP2E1—liver cancer	6.22e-06	6.61e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HMOX1—liver cancer	6.22e-06	6.61e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GOT1—liver cancer	6.11e-06	6.5e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GGT1—liver cancer	6.11e-06	6.5e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—MTHFR—liver cancer	6.05e-06	6.43e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CD—liver cancer	6.04e-06	6.42e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALDOB—liver cancer	6.04e-06	6.41e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.02e-06	6.4e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ALB—liver cancer	5.96e-06	6.34e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARA—liver cancer	5.93e-06	6.3e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—MTHFR—liver cancer	5.91e-06	6.28e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.9e-06	6.27e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.83e-06	6.19e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYCS—liver cancer	5.82e-06	6.18e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PSMD10—liver cancer	5.81e-06	6.18e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PSMA4—liver cancer	5.81e-06	6.18e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARA—liver cancer	5.8e-06	6.16e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTM1—liver cancer	5.79e-06	6.16e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CRABP1—liver cancer	5.76e-06	6.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GOT1—liver cancer	5.71e-06	6.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GGT1—liver cancer	5.71e-06	6.07e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GOT2—liver cancer	5.65e-06	6.01e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTP1—liver cancer	5.63e-06	5.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HMOX1—liver cancer	5.55e-06	5.9e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTP1—liver cancer	5.49e-06	5.84e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP1A1—liver cancer	5.49e-06	5.84e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HMOX1—liver cancer	5.42e-06	5.75e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP2E1—liver cancer	5.32e-06	5.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CB—liver cancer	5.26e-06	5.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTM1—liver cancer	5.17e-06	5.49e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.15e-06	5.47e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTP1—liver cancer	5.13e-06	5.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—MTHFR—liver cancer	5.12e-06	5.44e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CG—liver cancer	5.08e-06	5.4e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HMOX1—liver cancer	5.06e-06	5.38e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTM1—liver cancer	5.05e-06	5.36e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HPGDS—liver cancer	5.03e-06	5.35e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARA—liver cancer	5.02e-06	5.34e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYCS—liver cancer	4.97e-06	5.29e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CG—liver cancer	4.97e-06	5.28e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARG—liver cancer	4.9e-06	5.21e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP1A1—liver cancer	4.9e-06	5.21e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GOT1—liver cancer	4.88e-06	5.19e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GGT1—liver cancer	4.88e-06	5.19e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARG—liver cancer	4.79e-06	5.09e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP1A1—liver cancer	4.78e-06	5.08e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTM1—liver cancer	4.71e-06	5.01e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CA—liver cancer	4.7e-06	4.99e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—MTHFR—liver cancer	4.57e-06	4.86e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.51e-06	4.79e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PSMD10—liver cancer	4.49e-06	4.77e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PSMA4—liver cancer	4.49e-06	4.77e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARA—liver cancer	4.48e-06	4.76e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP1A1—liver cancer	4.47e-06	4.75e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CD—liver cancer	4.47e-06	4.75e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—MTHFR—liver cancer	4.46e-06	4.74e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ALB—liver cancer	4.41e-06	4.69e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTP1—liver cancer	4.38e-06	4.66e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARA—liver cancer	4.38e-06	4.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CD—liver cancer	4.37e-06	4.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GOT2—liver cancer	4.36e-06	4.64e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HMOX1—liver cancer	4.32e-06	4.59e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ALB—liver cancer	4.31e-06	4.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CG—liver cancer	4.3e-06	4.57e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—MTHFR—liver cancer	4.17e-06	4.43e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARG—liver cancer	4.15e-06	4.41e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP2E1—liver cancer	4.1e-06	4.36e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARA—liver cancer	4.09e-06	4.34e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTM1—liver cancer	4.03e-06	4.28e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.03e-06	4.28e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CB—liver cancer	3.89e-06	4.14e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CG—liver cancer	3.84e-06	4.08e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYCS—liver cancer	3.84e-06	4.08e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—liver cancer	3.84e-06	4.08e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP1A1—liver cancer	3.82e-06	4.06e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CB—liver cancer	3.8e-06	4.04e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CD—liver cancer	3.78e-06	4.02e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GOT1—liver cancer	3.77e-06	4e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GGT1—liver cancer	3.77e-06	4e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CG—liver cancer	3.75e-06	3.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALB—liver cancer	3.73e-06	3.97e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARG—liver cancer	3.71e-06	3.94e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.67e-06	3.9e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARG—liver cancer	3.62e-06	3.84e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—MTHFR—liver cancer	3.56e-06	3.78e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CG—liver cancer	3.5e-06	3.72e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARA—liver cancer	3.49e-06	3.71e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTP1—liver cancer	3.38e-06	3.6e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARG—liver cancer	3.38e-06	3.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CD—liver cancer	3.37e-06	3.59e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HMOX1—liver cancer	3.34e-06	3.55e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALB—liver cancer	3.33e-06	3.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CB—liver cancer	3.3e-06	3.5e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CD—liver cancer	3.29e-06	3.5e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALB—liver cancer	3.25e-06	3.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CA—liver cancer	3.21e-06	3.41e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.14e-06	3.33e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTM1—liver cancer	3.11e-06	3.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CD—liver cancer	3.08e-06	3.27e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALB—liver cancer	3.04e-06	3.23e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CG—liver cancer	2.99e-06	3.18e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP1A1—liver cancer	2.95e-06	3.13e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CB—liver cancer	2.94e-06	3.13e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARG—liver cancer	2.89e-06	3.07e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CB—liver cancer	2.87e-06	3.05e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MTHFR—liver cancer	2.75e-06	2.92e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARA—liver cancer	2.7e-06	2.86e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CB—liver cancer	2.68e-06	2.85e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CD—liver cancer	2.63e-06	2.79e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—liver cancer	2.62e-06	2.79e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALB—liver cancer	2.6e-06	2.76e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CA—liver cancer	2.37e-06	2.52e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CA—liver cancer	2.32e-06	2.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.31e-06	2.45e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.29e-06	2.44e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARG—liver cancer	2.23e-06	2.37e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.03e-06	2.16e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CA—liver cancer	2.01e-06	2.13e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALB—liver cancer	2e-06	2.13e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—liver cancer	1.94e-06	2.06e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—liver cancer	1.89e-06	2.01e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CA—liver cancer	1.79e-06	1.91e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.77e-06	1.88e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CA—liver cancer	1.75e-06	1.86e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—liver cancer	1.64e-06	1.74e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.64e-06	1.74e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—liver cancer	1.46e-06	1.56e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—liver cancer	1.43e-06	1.52e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.4e-06	1.48e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—liver cancer	1.34e-06	1.42e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—liver cancer	1.14e-06	1.21e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.08e-06	1.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—liver cancer	8.81e-07	9.36e-06	CbGpPWpGaD
